Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Clinical Value and Regulatory Mechanism of miR-767-5p in Colorectal Cancer

P. Lin, X. Qin, C. Yi, M. Jiang, L. Yi, Y. Liang

. 2025 ; 71 (1) : 18-28. [pub] -

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25011625

The poor prognosis of colorectal cancer (CRC) contributes to a yearly increase in CRC mortality, while microRNAs (miRNAs) were found to play a regulatory function in diversiform cancers, including CRC. The objective of this research was to evaluate the clinical value and possible regulatory mechanisms of miR-767-5p in CRC. The expression level of miR-767-5p in CRC tissues and cells was examined. The Kaplan-Meier curve was utilized to analyse the function of miR-767-5p in CRC prognosis. The independent prognostic factors in CRC were assessed by a multivariate COX regression analysis. Additionally, the regulatory mechanism of miR-767-5p in CRC was determined through an in vitro cell experiment. The miR-767-5p expression was down-regulated in CRC tumour tissues and CRC cells. Indicators such as tumour differentiation, TNM, LNM and miR-767-5p were identified as independent prognostic factors for a poor CRC prognosis. The regulatory relationship between miR-767-5p and nuclear factor I A (NFIA) was verified by the dual-luciferase reporter assay, and the NFIA expression level was significantly suppressed by over-expressed miR-767-5p. The proliferation, migration and invasion of CRC cells were inhibited by over-expressing miR-767-5p, while the inhibition effect could be reversed by over-expressing NFIA. The over-expressed miR-767-5p could serve as a tumour suppressor to inhibit the progression of CRC by suppressing the expression level of NFIA.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25011625
003      
CZ-PrNML
005      
20250521143009.0
007      
ta
008      
250506s2025 xr da f 000 0|eng||
009      
AR
024    7_
$a 10.14712/fb2025071010018 $2 doi
035    __
$a (PubMed)40308200
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Lin, Ping $u Department of General Surgery, Minimally Invasive Surgery Center, Second People's Hospital of Hunan Province (Hunan Brain Hospital), Changsha, China
245    10
$a Clinical Value and Regulatory Mechanism of miR-767-5p in Colorectal Cancer / $c P. Lin, X. Qin, C. Yi, M. Jiang, L. Yi, Y. Liang
520    9_
$a The poor prognosis of colorectal cancer (CRC) contributes to a yearly increase in CRC mortality, while microRNAs (miRNAs) were found to play a regulatory function in diversiform cancers, including CRC. The objective of this research was to evaluate the clinical value and possible regulatory mechanisms of miR-767-5p in CRC. The expression level of miR-767-5p in CRC tissues and cells was examined. The Kaplan-Meier curve was utilized to analyse the function of miR-767-5p in CRC prognosis. The independent prognostic factors in CRC were assessed by a multivariate COX regression analysis. Additionally, the regulatory mechanism of miR-767-5p in CRC was determined through an in vitro cell experiment. The miR-767-5p expression was down-regulated in CRC tumour tissues and CRC cells. Indicators such as tumour differentiation, TNM, LNM and miR-767-5p were identified as independent prognostic factors for a poor CRC prognosis. The regulatory relationship between miR-767-5p and nuclear factor I A (NFIA) was verified by the dual-luciferase reporter assay, and the NFIA expression level was significantly suppressed by over-expressed miR-767-5p. The proliferation, migration and invasion of CRC cells were inhibited by over-expressing miR-767-5p, while the inhibition effect could be reversed by over-expressing NFIA. The over-expressed miR-767-5p could serve as a tumour suppressor to inhibit the progression of CRC by suppressing the expression level of NFIA.
650    12
$a mikro RNA $x genetika $x metabolismus $7 D035683
650    _2
$a lidé $7 D006801
650    12
$a kolorektální nádory $x genetika $x patologie $x metabolismus $7 D015179
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a proliferace buněk $x genetika $7 D049109
650    _2
$a prognóza $7 D011379
650    _2
$a pohyb buněk $x genetika $7 D002465
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a transkripční faktory NFI $x metabolismus $x genetika $7 D051839
650    _2
$a invazivní růst nádoru $7 D009361
650    _2
$a senioři $7 D000368
650    _2
$a Kaplanův-Meierův odhad $7 D053208
655    _2
$a časopisecké články $7 D016428
700    1_
$a Qin, Xiuju $u Department of Oncology, No. 971 Navy Hospital of the Chinese People's Liberation Army, Qingdao, China
700    1_
$a Yi, Caiyun $u Department of Nursing, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, China
700    1_
$a Jiang, Man $u Department of Hospice, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, China
700    1_
$a Yi, Lili $u Department of Nursing, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, China. yilili_xiangya@163.com
700    1_
$a Liang, Yuemian $u Department of Pathology, Affiliated Hospital of Hebei University, Baoding, China. Liangyuemianhb@163.com
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 71, č. 1 (2025), s. 18-28
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40308200 $y Pubmed
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20250506 $b ABA008
991    __
$a 20250521143006 $b ABA008
999    __
$a ok $b bmc $g 2324876 $s 1248715
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 71 $c 1 $d 18-28 $e - $i 0015-5500 $m Folia biologica $n Folia Biol (Praha) $x MED00011004
LZP    __
$b NLK116 $a Pubmed-20250506

Najít záznam

Citační ukazatele

Možnosti archivace